10 top-selling drugs of 2018

In 2018, Abbvie's rheumatoid arthritis drug Humira once again topped the list of best-selling drugs, according to a new analysis published in Nature.

Below is a breakdown of the 10 top-selling drugs globally:

1. Humira (AbbVie) $19.9 billion

2. Revlimid (Celgene) $9.7 billion

3. Keytruda (Merck & Co.) $7.2 billion

4. Herceptin (Roche) $7.1 billion

5. Avastin (Roche) $7.0 billion

6. Rituxan (Roche) $6.9 billion

7. Opdivo (Bristol-Myers Squibb) $6.7 billion

8. Eliquis (Bristol-Myers Squibb) $6.4 billion

9. Prevnar 13 (Pfizer) $5.8 billion

10. Stelara (Johnson & Johnson) $5.2 billion

More articles on pharmacy:
Bristol-Myers urges shareholders to support Celgene takeover
Novartis to pay $23M to settle claims it used charity payments as kickbacks
Martin Shkreli reportedly running his pharma company from prison

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.